These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients. Vakil N; Zullo A; Ricci C; Hassan C; Vaira D Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1304-8. PubMed ID: 18774949 [TBL] [Abstract][Full Text] [Related]
43. Helicobacter pylori and the pathogenesis of gastroduodenal disease: Implications for the management of peptic ulcer disease. Rotimt O; Nduduba DA; Otegbeye FM Niger Postgrad Med J; 2005 Dec; 12(4):289-98. PubMed ID: 16380742 [TBL] [Abstract][Full Text] [Related]
44. Treatment of Helicobacter pylori infection. Cavallaro LG; Egan B; O'Morain C; Di Mario F Helicobacter; 2006 Oct; 11 Suppl 1():36-9. PubMed ID: 16925610 [TBL] [Abstract][Full Text] [Related]
45. Pylera for the eradication of Helicobacter pylori infection. Saleem A; Qasim A; O'Connor HJ; O'Morain CA Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221 [TBL] [Abstract][Full Text] [Related]
46. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study. Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938 [TBL] [Abstract][Full Text] [Related]
47. [Clinical importance of Helicobacter pylori infection in patients with diabetes mellitus]. Bures J; Smahelová A; Kopácová M; Rejchrt S Vnitr Lek; 2004 May; 50(5):350-3. PubMed ID: 15305630 [TBL] [Abstract][Full Text] [Related]
48. Statistical annex: statistical aspects of clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. Gut; 1997 Sep; 41 Suppl 2():S19-23. PubMed ID: 9404238 [No Abstract] [Full Text] [Related]
49. [Helicobacter pylori]. Macipe Costa RM; Gimeno Feliu LA; Feja Solana T; Ruiz Ferrando E Med Clin (Barc); 1996 Sep; 107(8):317. PubMed ID: 8965497 [No Abstract] [Full Text] [Related]
50. The current status of Helicobacter pylori as a pathogen in upper gastrointestinal tract. Barbezat GO N Z Med J; 1994 Nov; 107(990):478-80. PubMed ID: 7970364 [No Abstract] [Full Text] [Related]
51. Treatment failures and secondary resistance to antibiotics. A growing concern in Helicobacter pylori therapy. de Boer WA; Borody TJ Dig Liver Dis; 2000 Nov; 32(8):673-5. PubMed ID: 11142575 [No Abstract] [Full Text] [Related]
55. [Helicobacter pylori: diffusion of the information in Finland]. Rautanen K; Thomsen AS; Hjalt CA; Jónsson A; Martin P; Löfroth G Duodecim; 1998; 114(17):1721-6. PubMed ID: 11717778 [No Abstract] [Full Text] [Related]
56. Proceedings of the 2nd National Workshop on Helicobacter pylori: Management recommendations in India. Thrissur, Kerala, February 20, 1999. Indian J Gastroenterol; 2000 Aug; 19 Suppl 1():S1-40. PubMed ID: 11203039 [No Abstract] [Full Text] [Related]
57. Reflux oesophagitis after Helicobacter pylori treatment. Rinaldi V; Morini S; Zullo A; Hassan C; De Francesco V; Faleo D; Attili AF Dig Liver Dis; 2000 Nov; 32(8):749. PubMed ID: 11142592 [No Abstract] [Full Text] [Related]
58. [Acid-peptic disease associated with Helicobacter pylori in children. Report of a case]. Marañón Sepúlveda M Rev Gastroenterol Mex; 1992; 57(3):156. PubMed ID: 1308293 [No Abstract] [Full Text] [Related]